Related Experiment Videos
The kidney and antihypertensive therapy
The American Journal of Cardiology
|January 23, 1987
Summary
Modern antihypertensive drugs improve blood pressure by affecting renal function. This review details how vasodilators, beta-blockers, and other agents impact kidney perfusion and overall treatment efficacy.
Area of Science:
- Nephrology
- Pharmacology
- Cardiovascular Medicine
Background:
- Antihypertensive therapy has advanced beyond non-specific vasodilators.
- Understanding renal impact is crucial for effective blood pressure management.
Purpose of the Study:
- To review the effects of antihypertensive agents on renal perfusion and function.
- To correlate renal impact with efficacy in reducing high blood pressure.
Main Methods:
- Review of literature on antihypertensive agents and renal function.
- Analysis of specific drug classes: beta-adrenergic blocking agents, converting enzyme inhibitors, calcium channel blockers, and dopamine analogs.
- Examination of renal blood supply abnormalities in essential hypertension.
Main Results:
- Beta-adrenergic blocking agents exhibit minimal renal impact.
- Converting enzyme inhibitors, calcium channel blockers, and dopamine analogs offer specific mechanisms for blood pressure control.
- Reactive responses can limit therapeutic effectiveness.
Conclusions:
- Antihypertensive agents' effects on renal perfusion and function are key to their efficacy.
- Newer pharmacologic agents and understanding renal abnormalities are vital for optimizing hypertension treatment.